Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Mycophenolic acid derivative 118 improves outcome of skin grafts by suppressing IL-17 production.

Kong FY, Chen W, He SJ, Lin ZM, Li X, Zhang XH, Yang XQ, Zhu FH, Tong XK, Zhou Y, Tang W, Duan WH, Zuo JP.

Acta Pharmacol Sin. 2013 Jul;34(7):921-9. doi: 10.1038/aps.2013.14. Epub 2013 May 6.

2.

Neutralization of mouse interleukin-17 bioactivity inhibits corneal allograft rejection.

Chen X, Zhao S, Tang X, Ge H, Liu P.

Mol Vis. 2011;17:2148-56. Epub 2011 Aug 11.

3.

Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.

Obermajer N, Popp FC, Soeder Y, Haarer J, Geissler EK, Schlitt HJ, Dahlke MH.

J Immunol. 2014 Nov 15;193(10):4988-99. doi: 10.4049/jimmunol.1401776. Epub 2014 Oct 10.

4.

Changes in Th17 and IL-17 levels during acute rejection after mouse skin transplantation.

Zheng HL, Shi BY, Du GS, Wang Z.

Eur Rev Med Pharmacol Sci. 2014;18(18):2720-86.

5.

The imbalance between Treg and Th17 cells caused by FTY720 treatment in skin allograft rejection.

Commodaro AG, Pedregosa JF, Peron JP, Brandão W, Rizzo LV, Bueno V.

Clinics (Sao Paulo). 2012 Jul;67(7):805-13.

6.

Antisense deoxyoligonucleotides or antibodies to murine MD-1 inhibit rejection of allogeneic and xenogeneic skin grafts in C3H mice.

Hadidi S, Chen Z, Phillips J, Yu K, Gorczynski RM.

Transplantation. 2002 Jun 15;73(11):1771-9.

PMID:
12085000
7.
8.
10.

Effect of CD200 and CD200R1 expression within tissue grafts on increased graft survival in allogeneic recipients.

Yu K, Chen Z, Gorczynski R.

Immunol Lett. 2013 Jan;149(1-2):1-8. doi: 10.1016/j.imlet.2012.11.004. Epub 2012 Nov 21.

PMID:
23178470
11.

Enhanced allogeneic skin-graft survival using sCD95L, sCD152, interleukin-10 and transforming growth factor-beta in combination, and comparison with ciclosporin.

Zheng H, Du G, Zhao R, Tang B, Zhu N.

Clin Exp Dermatol. 2009 Aug;34(6):721-7. doi: 10.1111/j.1365-2230.2009.03237.x. Epub 2009 May 16.

PMID:
19456768
12.

Induction of regulatory T cells and indefinite survival of fully allogeneic cardiac grafts by ursodeoxycholic acid in mice.

Zhang Q, Nakaki T, Iwami D, Niimi M, Shirasugi N.

Transplantation. 2009 Dec 27;88(12):1360-70. doi: 10.1097/TP.0b013e3181bc2f4f.

PMID:
20029332
13.

T cell-dependent acceleration of chemoattractant cytokine gene expression during secondary rejection of allogeneic skin grafts.

Kondo T, Watarai Y, Novick AC, Toma H, Fairchild RL.

Transplantation. 1997 Mar 15;63(5):732-42.

PMID:
9075847
14.

Curcumin attenuates acute graft-versus-host disease severity via in vivo regulations on Th1, Th17 and regulatory T cells.

Park MJ, Moon SJ, Lee SH, Yang EJ, Min JK, Cho SG, Yang CW, Park SH, Kim HY, Cho ML.

PLoS One. 2013 Jun 20;8(6):e67171. doi: 10.1371/journal.pone.0067171. Print 2013.

15.

MD-1 expression regulates direct and indirect allorecognition.

Hadidi S, Gorczynski RM.

Tissue Antigens. 2004 Feb;63(2):132-41.

PMID:
14705984
16.

The secreted form of p28 subunit of interleukin (IL)-27 inhibits biological functions of IL-27 and suppresses anti-allogeneic immune responses.

Shimozato O, Sato A, Kawamura K, Chiyo M, Ma G, Li Q, Tagawa M.

Immunology. 2009 Sep;128(1 Suppl):e816-25. doi: 10.1111/j.1365-2567.2009.03088.x. Epub 2009 Mar 23.

17.

Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.

Velásquez-Lopera MM, Eaton VL, Lerret NM, Correa LA, Decresce RP, García LF, Jaramillo A.

Transpl Immunol. 2008 May;19(2):127-35. doi: 10.1016/j.trim.2008.02.003. Epub 2008 Mar 20.

PMID:
18503888
18.

Topical application of FTY720 and cyclosporin A prolong corneal graft survival in mice.

Liu Y, Jiang J, Xiao H, Wang X, Li Y, Gong Y, Wang D, Huang Y.

Mol Vis. 2012;18:624-33. Epub 2012 Mar 9.

19.

Inhibition of Pim2-prolonged skin allograft survival through the apoptosis regulation pathway.

Liu H, Zhang C, Liang T, Song J, Hao J, Hou G.

Cell Mol Immunol. 2012 Nov;9(6):503-10. doi: 10.1038/cmi.2012.41. Epub 2012 Oct 22.

20.

Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.

Margenthaler JA, Landeros K, Kataoka M, Flye MW.

Transpl Immunol. 2003 Jan-Mar;11(1):23-9.

PMID:
12727472

Supplemental Content

Support Center